5:00 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Milestone Pharmaceuticals Nasdaq/NYSE Compliance Notice
Milestone Pharmaceuticals received a deficiency notice from Nasdaq on October 23, 2026, because its common shares failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 21, 2027, to regain compliance by having its shares close at $1.00 or higher for at least 10 consecutive business days.
- Counterparty
- Nasdaq
- Term
- 180 days